Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 1
1988 2
1989 9
1990 20
1991 30
1992 32
1993 34
1994 42
1995 54
1996 62
1997 42
1998 50
1999 46
2000 42
2001 51
2002 49
2003 61
2004 55
2005 79
2006 79
2007 86
2008 83
2009 86
2010 81
2011 80
2012 82
2013 81
2014 83
2015 77
2016 84
2017 49
2018 57
2019 60
2020 64
2021 74
2022 63
2023 48
2024 48

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,949 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Erythropoietin Treatment in Patients with Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Yao X, Wang D, Li H, Shen H, Shu Z, Chen G. Yao X, et al. Curr Drug Deliv. 2017 Sep 6;14(6):853-860. doi: 10.2174/1567201813666160822104813. Curr Drug Deliv. 2017. PMID: 27549753 Review.
OBJECTIVE: Erythropoietin (EPO) for treating acute ischemic stroke (AIS) has been investigated in many studies. ...
OBJECTIVE: Erythropoietin (EPO) for treating acute ischemic stroke (AIS) has been investigated in many studies. ...
Erythropoietin: biology and clinical use.
Graber SE, Krantz SB. Graber SE, et al. Hematol Oncol Clin North Am. 1989 Sep;3(3):369-400. Hematol Oncol Clin North Am. 1989. PMID: 2561121 Review.
Red cell production in vertebrates is controlled by a glycoprotein hormone known as erythropoietin (Ep), which is produced by the kidney in response to hypoxia and acts on the marrow to selectively stimulate erythropoiesis. ...
Red cell production in vertebrates is controlled by a glycoprotein hormone known as erythropoietin (Ep), which is produced by the kid …
Erythropoietin or darbepoetin for patients with cancer.
Tonia T, Mettler A, Robert N, Schwarzer G, Seidenfeld J, Weingart O, Hyde C, Engert A, Bohlius J. Tonia T, et al. Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD003407. doi: 10.1002/14651858.CD003407.pub5. Cochrane Database Syst Rev. 2012. PMID: 23235597 Free PMC article. Review.
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial.
Platzbecker U, Della Porta MG, Santini V, Zeidan AM, Komrokji RS, Shortt J, Valcarcel D, Jonasova A, Dimicoli-Salazar S, Tiong IS, Lin CC, Li J, Zhang J, Giuseppi AC, Kreitz S, Pozharskaya V, Keeperman KL, Rose S, Shetty JK, Hayati S, Vodala S, Prebet T, Degulys A, Paolini S, Cluzeau T, Fenaux P, Garcia-Manero G. Platzbecker U, et al. Lancet. 2023 Jul 29;402(10399):373-385. doi: 10.1016/S0140-6736(23)00874-7. Epub 2023 Jun 10. Lancet. 2023. PMID: 37311468 Clinical Trial.
In this study, we report the results of a prespecified interim analysis of luspatercept versus epoetin alfa for the treatment of anaemia due to lower-risk myelodysplastic syndromes in the phase 3 COMMANDS trial. ...The interim efficacy analysis was done for 301 pati …
In this study, we report the results of a prespecified interim analysis of luspatercept versus epoetin alfa for the treatment …
Erythropoietin or darbepoetin for patients with cancer.
Bohlius J, Wilson J, Seidenfeld J, Piper M, Schwarzer G, Sandercock J, Trelle S, Weingart O, Bayliss S, Brunskill S, Djulbegovic B, Benett CL, Langensiepen S, Hyde C, Engert E. Bohlius J, et al. Cochrane Database Syst Rev. 2006 Jul 19;(3):CD003407. doi: 10.1002/14651858.CD003407.pub4. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2012 Dec 12;12:CD003407. doi: 10.1002/14651858.CD003407.pub5 PMID: 16856007 Updated. Review.
Therapeutic alternatives are recombinant human erythropoietin (Epo), darbepoetin (Darbepo) and red blood cell transfusions. OBJECTIVES: The aim of this systematic review was to assess the effects of Epo or Darbepo to either prevent or treat anaemia in cancer patients. ...
Therapeutic alternatives are recombinant human erythropoietin (Epo), darbepoetin (Darbepo) and red blood cell transfusions. OBJECTIVE …
Erythropoietin to treat anaemia in critical care patients: a multicentre feasibility study.
Léger M, Auchabie J, Ferrandière M, Parot-Schinkel E, Campfort M, Rineau E, Lasocki S. Léger M, et al. Anaesthesia. 2023 Aug;78(8):979-987. doi: 10.1111/anae.16038. Epub 2023 May 15. Anaesthesia. 2023. PMID: 37184109 Free article. Clinical Trial.
In this study, we aimed to evaluate the feasibility of performing a large multicentre randomised controlled trial of erythropoietin in this setting. We randomly allocated patients staying in the ICU for 72 h with haemoglobin 120 g.l(-1) to either a weekly injection of e …
In this study, we aimed to evaluate the feasibility of performing a large multicentre randomised controlled trial of erythropoietin i …
Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis.
Singh AK, Carroll K, Perkovic V, Solomon S, Jha V, Johansen KL, Lopes RD, Macdougall IC, Obrador GT, Waikar SS, Wanner C, Wheeler DC, Więcek A, Blackorby A, Cizman B, Cobitz AR, Davies R, Dole J, Kler L, Meadowcroft AM, Zhu X, McMurray JJV; ASCEND-D Study Group. Singh AK, et al. N Engl J Med. 2021 Dec 16;385(25):2325-2335. doi: 10.1056/NEJMoa2113379. Epub 2021 Nov 5. N Engl J Med. 2021. PMID: 34739194 Free article. Clinical Trial.
BACKGROUND: Among patients with chronic kidney disease (CKD), the use of recombinant human erythropoietin and its derivatives for the treatment of anemia has been linked to a possibly increased risk of stroke, myocardial infarction, and other adverse events. ...METHODS: In …
BACKGROUND: Among patients with chronic kidney disease (CKD), the use of recombinant human erythropoietin and its derivatives for the …
Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study.
Fishbane S, Pollock CA, El-Shahawy M, Escudero ET, Rastogi A, Van BP, Frison L, Houser M, Pola M, Little DJ, Guzman N, Pergola PE. Fishbane S, et al. J Am Soc Nephrol. 2022 Apr;33(4):850-866. doi: 10.1681/ASN.2020111638. J Am Soc Nephrol. 2022. PMID: 35361724 Free PMC article. Clinical Trial.
RESULTS: Among 2133 patients randomized (n=1068 roxadustat, n=1065 epoetin alfa), mean age was 54.0 years, and 89.1% and 10.8% were on hemodialysis and peritoneal dialysis, respectively. ...The proportion of patients experiencing 1 AE and 1 serious AE was 85.0% and …
RESULTS: Among 2133 patients randomized (n=1068 roxadustat, n=1065 epoetin alfa), mean age was 54.0 years, and 89.1% and 10.8% …
Erythropoietin in children with hemolytic uremic syndrome: a pilot randomized controlled trial.
Balestracci A, Capone MA, Meni Battaglia L, Toledo I, Martin SM, Beaudoin L, Balbaryski J, Gómez L. Balestracci A, et al. Pediatr Nephrol. 2022 Oct;37(10):2383-2392. doi: 10.1007/s00467-022-05474-9. Epub 2022 Feb 15. Pediatr Nephrol. 2022. PMID: 35166922 Clinical Trial.
BACKGROUND: The efficacy of recombinant human erythropoietin (rHuEPO) in sparing red blood cell (RBC) transfusions in children with hemolytic uremic syndrome related to Shiga toxin-producing Escherichia coli (STEC-HUS) is uncertain. ...
BACKGROUND: The efficacy of recombinant human erythropoietin (rHuEPO) in sparing red blood cell (RBC) transfusions in children with h …
Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data.
Bohlius J, Schmidlin K, Brillant C, Schwarzer G, Trelle S, Seidenfeld J, Zwahlen M, Clarke MJ, Weingart O, Kluge S, Piper M, Napoli M, Rades D, Steensma D, Djulbegovic B, Fey MF, Ray-Coquard I, Moebus V, Thomas G, Untch M, Schumacher M, Egger M, Engert A. Bohlius J, et al. Cochrane Database Syst Rev. 2009 Jul 8;2009(3):CD007303. doi: 10.1002/14651858.CD007303.pub2. Cochrane Database Syst Rev. 2009. PMID: 19588423 Free PMC article. Review.
SELECTION CRITERIA: We included randomized controlled trials comparing epoetin or darbepoetin plus red blood cell transfusions (as necessary) versus red blood cell transfusions (as necessary) alone, to prevent or treat anemia in adult or pediatric cancer patients with or w …
SELECTION CRITERIA: We included randomized controlled trials comparing epoetin or darbepoetin plus red blood cell transfusions (as ne …
1,949 results

Searches related to "erythropoietin"